Humira - Pharmacy Freak

Mechanism of Action of Humira

August 22, 2026 Harsh Singh Rajput

Introduction Humira is the brand name of adalimumab, a biologic immunomodulatory medicine that belongs to the tumor necrosis factor blocker class. More specifically, adalimumab is a recombinant human IgG1 monoclonal antibody directed against tumor necrosis factor-alpha, commonly abbreviated as TNF-α. TNF-α is a pro-inflammatory cytokine with an important role in normal immune defense. When produced … Read more

Mechanism of Action of Adalimumab (Humira)

April 10, 2026July 4, 2025 Pharmacy Freak Editorial Team Harsh Singh Rajput

Introduction Adalimumab is a fully human monoclonal IgG1 antibody that specifically targets tumor necrosis factor‑α (TNF‑α). By neutralizing TNF‑α, it reduces inflammation across a variety of autoimmune conditions, including rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), Crohn’s disease, ulcerative colitis, and plaque psoriasis. Step-by-Step Mechanism of Action Pharmacokinetic Parameters Parameter Value Route Subcutaneous … Read more